2 Fast-Growing Pharmaceutical Stocks to Buy Now
(NASDAQ: INCY) and TG Therapeutics (NASDAQ: TGTX) are commercial-stage biotech companies that are using blockbuster drugs to fund the growth of their promising pipelines. Incyte is known for its work in Janus kinase (JAK) inhibition, focusing on dermatology, oncology, hematology, inflammation, and autoimmune disorders.TG Therapeutics is focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases.
Both stocks are delivering strong returns. Shares of Incyte are up more than 17% this year, while TG Therapeutics is up nearly 90% so far in 2026.
Here are reasons to buy the pharmaceutical stocks:
Source Fool.com
Incyte Corp. Stock
The stock is one of the favorites of our community with 25 Buy predictions and 1 Sell predictions.
With a target price of 114 € there is a slightly positive potential of 9.09% for Incyte Corp. compared to the current price of 104.5 €.


